Comparison of 4L Polyethylene Glycol and 2L Polyethylene Glycol With Ascorbic Acid in Inactive UC Patients

Comparison of 4L Polyethylene Glycol and 2L Polyethylene Glycol With Ascorbic Acid in Patients With Inactive Ulcerative Colitis; Randomized, Single Blind, Multicenter Study

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01929668

Acronym

2SCANI

Enrollment

114

Registered

2013-08-28

Start date

2013-08-31

Completion date

2014-12-31

Last updated

2016-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative Colitis

Keywords

ulcerative colitis, bowel preparation

Brief summary

The purpose of this study is to compare preference of the patients, efficacy of preparation, and safety between 4 L polyethylene glycol and 2 L of polyethylene glycol with ascorbic acid in patients with inactive ulcerative colitis.

Interventions

DRUGpolyethylene glycol

DRUGAscorbic Acid

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SCREENING

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* age \>18 years old * ulcerative colitis patients without symptoms for at least 1 year * ulcerative colitis patients who undergo colonoscopy for surveillance

Exclusion criteria

* subjects who had abdominal surgery * pregnant or breast feeding

Design outcomes

Primary

Measure	Time frame
Number of patients who are willing to use the same preparation method for the next colonoscopy.	day 1

Secondary

Measure	Time frame
Number of patients who have ulcerative colitis symptom aggravation within 30 days after bowel preparation, measured by simple clinical colitis activity index (SCCAI).	within 30 days after bowel preparation for colonoscopy

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026